4.04
price up icon4.94%   0.19
after-market After Hours: 4.04
loading
Sight Sciences Inc stock is traded at $4.04, with a volume of 279.20K. It is up +4.94% in the last 24 hours and down -22.01% over the past month. Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.
See More
Previous Close:
$3.85
Open:
$3.9
24h Volume:
279.20K
Relative Volume:
0.85
Market Cap:
$218.18M
Revenue:
$77.36M
Net Income/Loss:
$-38.43M
P/E Ratio:
-5.4536
EPS:
-0.7408
Net Cash Flow:
$-29.92M
1W Performance:
+9.49%
1M Performance:
-22.01%
6M Performance:
+17.78%
1Y Performance:
+50.19%
1-Day Range:
Value
$3.89
$4.11
1-Week Range:
Value
$3.41
$4.11
52-Week Range:
Value
$2.03
$9.2362

Sight Sciences Inc Stock (SGHT) Company Profile

Name
Name
Sight Sciences Inc
Name
Phone
(415) 889-0550
Name
Address
4040 CAMPBELL AVE,, MENLO PARK
Name
Employee
186
Name
Twitter
Name
Next Earnings Date
2025-03-05
Name
Latest SEC Filings
Name
SGHT's Discussions on Twitter

Compare SGHT vs ABT, SYK, MDT, BSX, EW

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
SGHT icon
SGHT
Sight Sciences Inc
4.04 207.92M 77.36M -38.43M -29.92M -0.7408
ABT icon
ABT
Abbott Laboratories
104.83 180.82B 44.33B 6.50B 7.40B 3.717
SYK icon
SYK
Stryker Corp
327.65 125.72B 25.12B 3.25B 4.28B 8.3984
MDT icon
MDT
Medtronic Plc
87.89 111.16B 35.48B 4.64B 5.41B 3.582
BSX icon
BSX
Boston Scientific Corp
69.78 101.28B 20.08B 2.89B 3.66B 1.9391
EW icon
EW
Edwards Lifesciences Corp
82.67 47.45B 6.07B 1.06B 1.34B 1.8063

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-05-26 Upgrade Piper Sandler Neutral → Overweight
Aug-08-25 Upgrade Lake Street Hold → Buy
Dec-06-24 Initiated UBS Buy
Nov-04-24 Downgrade Lake Street Buy → Hold
Aug-21-24 Initiated Lake Street Buy
Sep-12-23 Downgrade BofA Securities Neutral → Underperform
Sep-12-23 Downgrade Piper Sandler Overweight → Neutral
Sep-12-23 Downgrade William Blair Outperform → Mkt Perform
Aug-24-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Jul-10-23 Downgrade Citigroup Buy → Neutral
Jan-06-23 Upgrade Stifel Hold → Buy
Oct-04-22 Initiated Needham Hold
Jul-26-22 Initiated Stifel Hold
Feb-03-22 Initiated William Blair Outperform
Jan-07-22 Upgrade Morgan Stanley Equal-Weight → Overweight
View All

Sight Sciences Inc Stock (SGHT) Latest News

pulisher
Mar 24, 2026

Sight Sciences Inc stock faces pressure amid weak Q4 guidance and slowing growth in eye care devices - AD HOC NEWS

Mar 24, 2026
pulisher
Mar 18, 2026

Citigroup maintains Sight Sciences (SGHT) neutral recommendation - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy - MSN

Mar 18, 2026
pulisher
Mar 17, 2026

Can Sight Sciences Inc weather a recession2026 Technical Overview & Weekly High Conviction Trade Ideas - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 16, 2026

Earnings call transcript: Sight Sciences beats Q4 2025 forecasts, stock rises - Investing.com Nigeria

Mar 16, 2026
pulisher
Mar 14, 2026

Prosight Management LP Sells 431,746 Shares of Sight Sciences, Inc. $SGHT - MarketBeat

Mar 14, 2026
pulisher
Mar 12, 2026

Morgan Stanley Sticks to Its Hold Rating for Sight Sciences (SGHT) - The Globe and Mail

Mar 12, 2026
pulisher
Mar 11, 2026

Sight Sciences (SGHT) Q4 2025 Earnings Transcript - AOL.com

Mar 11, 2026
pulisher
Mar 10, 2026

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2025 earnings call transcript - MSN

Mar 10, 2026
pulisher
Mar 07, 2026

Sight Sciences Earnings Call Highlights Disciplined Growth - TipRanks

Mar 07, 2026
pulisher
Mar 07, 2026

Stock Report: Can Sight Sciences Inc weather a recession2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Sight Sciences, Inc. (SGHT) reports Q4 loss, beats revenue estimates - MSN

Mar 06, 2026
pulisher
Mar 06, 2026

S P Trends: Will Sight Sciences Inc outperform tech stocks2025 Bull vs Bear & Long-Term Safe Investment Ideas - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Sight Sciences Shareholders Are Encouraged to Reach Out to - GlobeNewswire

Mar 06, 2026
pulisher
Mar 06, 2026

Sight Sciences (NASDAQ:SGHT) Price Target Cut to $11.00 by Analysts at UBS Group - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Sight Sciences (NASDAQ:SGHT) Price Target Lowered to $6.50 at Citigroup - MarketBeat

Mar 06, 2026
pulisher
Mar 06, 2026

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 06, 2026
pulisher
Mar 06, 2026

Sight Sciences (SGHT) reports Q4 earnings: What key metrics have to say - MSN

Mar 06, 2026
pulisher
Mar 06, 2026

William Blair Maintains Outperform on SGHT Sight Sciences, Inc. March 2026 - Meyka

Mar 06, 2026
pulisher
Mar 06, 2026

Sight Sciences Reports Preliminary Fourth Quarter 2025 Revenue Growth, Provides 2026 Outlook - VisionMonday.com

Mar 06, 2026
pulisher
Mar 05, 2026

Sight Sciences (SGHT) EPS Loss Narrows Again And Tests Bearish Profitability Narratives - simplywall.st

Mar 05, 2026
pulisher
Mar 05, 2026

William Blair reiterates Sight Sciences stock rating on expense control - Investing.com Nigeria

Mar 05, 2026
pulisher
Mar 05, 2026

William Blair reiterates Sight Sciences stock rating on expense control By Investing.com - Investing.com India

Mar 05, 2026
pulisher
Mar 05, 2026

Sight Sciences, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Mar 05, 2026
pulisher
Mar 05, 2026

Sight Sciences Q4 Net Loss Narrows; Expects 6-14% Revenue Growth In FY26 - Nasdaq

Mar 05, 2026
pulisher
Mar 04, 2026

Sight Sciences sees FY26 revenue $82M-$88M, consensus $86.11M - TipRanks

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences Q4 2025 Earnings Call Transcript - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Earnings call transcript: Sight Sciences beats Q4 2025 forecasts, stock rises By Investing.com - Investing.com South Africa

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences Q4 Earnings Call Highlights - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates - Bitget

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences (SGHT) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences reports Q4 EPS (8c), consensus (14c) - TipRanks

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences Q4 Loss Narrows, Revenue Rises - marketscreener.com

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences earnings beat by $0.07, revenue topped estimates - Investing.com Canada

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences Inc. (SGHT) Stock Falls on Q4 2025 Earnings - Quiver Quantitative

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences (NASDAQ:SGHT) Posts Quarterly Earnings Results - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences Q4 Earnings Assessment - Benzinga

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences Posts Q4 Growth, Issues 2026 Outlook - TipRanks

Mar 04, 2026
pulisher
Mar 04, 2026

SGHT: OMNI and TearCare drive innovation in eyecare, targeting large, underserved markets - TradingView

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Initiates Full Year 2026 Financial Guidance - The Manila Times

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences (SGHT) outlines interventional glaucoma and dry eye growth plan - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and 2026 Guidance - Quiver Quantitative

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences (NASDAQ: SGHT) narrows 2025 loss and targets 6–14% growth - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Eye-care firm Sight Sciences targets up to 14% 2026 growth after $38M 2025 loss - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

SGHT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026
pulisher
Mar 04, 2026

Sight Sciences Inc (SGHT) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Mar 04, 2026
pulisher
Mar 03, 2026

Uncovering Potential: Sight Sciences's Earnings Preview - Benzinga

Mar 03, 2026
pulisher
Mar 02, 2026

5 Analysts Assess Sight Sciences: What You Need To Know - Benzinga

Mar 02, 2026
pulisher
Mar 02, 2026

Stifel raises Sight Sciences stock price target on TearCare survey By Investing.com - Investing.com Canada

Mar 02, 2026
pulisher
Mar 02, 2026

Stifel Nicolaus Issues Positive Forecast for Sight Sciences (NASDAQ:SGHT) Stock Price - MarketBeat

Mar 02, 2026

Sight Sciences Inc Stock (SGHT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
ZBH ZBH
$87.64
price up icon 1.53%
STE STE
$223.38
price up icon 0.74%
$66.84
price up icon 0.36%
PHG PHG
$27.44
price up icon 2.66%
$72.20
price up icon 1.75%
EW EW
$82.67
price up icon 1.20%
Cap:     |  Volume (24h):